Fatty Acid Oxidation

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/20

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 5:32 AM on 4/29/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

21 Terms

1
New cards

Describe the 3 stages of fasting.

  1. glycogenolysis -- breakdown of glycogen to maintain blood sugar levels (~24 hrs)

  2. gluconeogenesis -- synthesizing glucose from non-carbohydrate precursors

  3. ketone utilization -- byproduct of fatty acid breakdown to supply energy to the brain

2
New cards

Describe a fatty acid molecule.

  • carboxylic acid group

  • chain of carbons linked together

    • trans -- functional groups on the opposite side

    • cis -- functional groups on the same side

3
New cards

Where does fatty acid beta-oxidation occur?

occurs primarily in the mitochondria of liver, skeletal muscle, and heart cells

4
New cards

Describe the carnitine shuttle.

  • the mitochondrial membrane is not permeable to long-chain fatty acids

    • fatty acids need to be shuttled into mitochondrial matrix via carnitine

5
New cards

What is the first step in beta-oxidation?

  • acyl-CoA dehydrogenase -- fatty acyl-CoA is metabolized

    • short-chain acyl-CoA dehydrogenase

    • medium-chain acyl-CoA dehydrogenase

    • very long-chain acyl-CoA dehydrogenase

6
New cards

What are the general clinical presentations of fatty acid oxidation disorders?

newborns:

  • cardiomyopathy, hypoketotic hypoglycemia, liver dysfunction

infantile-onset:

  • lethargy and vomiting

late childhood/adult onset:

  • muscle weakness, renal damage

7
New cards

What are the general dietary guidelines of FAOD?

  • avoid periods of fasting

  • complex carbohydrate intake

  • low fat meals

  • MCT oil & carnitine supplementation

8
New cards

Describe the dysfunctional pathway of medium-chain acyl-CoA dehydrogenase deficiency.

  • mutation in the ACADM gene (single nucleotide chain -- lysine to glutamate)

    • medium-chain acyl-CoA dehydrogenase is unable to break down the medium-chain acyl-CoA into acetyl-CoA

<ul><li><p>mutation in the ACADM gene (single nucleotide chain -- lysine to glutamate)</p><ul><li><p>medium-chain acyl-CoA dehydrogenase is unable to break down the medium-chain acyl-CoA into acetyl-CoA</p></li></ul></li></ul><p></p>
9
New cards

What are the symptoms of MCADD?

  • newborns/infants: altered mental status, emesis, dehydration, drowsiness, and poor feeding

  • adolescents/adults:

    • metabolic crisis -- metabolic acidosis, hyperammonemia, hyperlactacidemia, hypoglycemia

    • multi-organ involvement -- neurological, muscular, hepatic, or cardiac symptoms

10
New cards

What are the biochemical values of MCADD?

  • increased hexanoylglycine and dicarboxylic acids in the urine

  • elevated acylcarnitines

11
New cards

Describe the dysfunctional pathway of very long-chain acyl-CoA dehydrogenase deficiency.

  • mutation in the ACADVL gene

    • very long-chain acyl-CoA dehydrogenase is unable to break down the very long-chain acyl-CoA into acetyl-CoA

    • results in toxic derivatives that accumulate and cause damage to the cardiac, hepatic, and muscular tissues

12
New cards

What are the symptoms of VLCADD?

  • acute cardiomyopathy

  • hypotonia

  • hepatomegaly

  • intermittent hypoglycemia

  • myopathy

13
New cards

How is VLCADD diagnosed?

  • positive newborn screening test

    • increase in long-chain acylcarnitines

  • other testing: genetic testing, enzymatic assays

14
New cards

What is the tri-functional protein?

  • enzyme complex that catalyzes the last 3 steps in beta-oxidation

    • bound to inner-mitochondrial membrane

<ul><li><p>enzyme complex that catalyzes the last 3 steps in beta-oxidation</p><ul><li><p>bound to inner-mitochondrial membrane</p></li></ul></li></ul><p></p>
15
New cards

Describe the dysfunctional pathway of tri-functional protein defect (TFPD).

  • mutations in HADHA or HADHB cause TFPD to lose enzymatic functions

16
New cards

What are the clinical presentations of TFPD?

  • neonatal onset -- severe form

  • infantile onset -- intermediate form

  • late adolescent onset -- mild form

17
New cards

How is TFDP diagnosed?

  • elevated levels of 3-hydroxy palmitoyl carnitine

    • other testing: enzymatic assays, identify bi-allelic mutations in HADHA/HADHB

18
New cards

Describe the dysfunctional pathway of carnitine uptake defect (CUD).

  • mutations in SLC22A5 gene that encodes for the organic carnitine transporter novel type 2

    • OCTN2 is highly expressed in the heart, muscle, kidneys, and other tissues

  • defective fatty acid oxidation pathway

19
New cards

What are the biochemical values of dysfunctional OCTN2?

  • urinary carnitine wasting

  • low serum and intracellular carnitine levels

20
New cards

What is the clinical presentation of CUD?

  • defective fatty acid oxidation results in:

    • hypoglycemia due to excessive glucose consumption

    • ectopic fat accumulation in the liver, skeletal muscles, and heart

      • causes … steatosis, myopathy, and cardiomyopathy

21
New cards

How is CUD diagnosed?

  • reduced free and total carnitine

  • genetic testing